Sabra Health Care Reit, Inc.
$7.77B- Market cap
- $5.31B
- Debt
- +$2.53B
- Cash
- −$71.54M
Capital structure 68% equity / 32% debt · EV / Revenue 10.03x · EV / EBITDA 27.03x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SBRA stock price at premium vs POWL $20.80 current versus $7.80 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at POWL's multiple
Implied fair value · at SBRA's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SBRA FY 2025 (ended Dec 31, 2025) · POWL FY 2025 (ended Sep 30, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 68% equity / 32% debt · EV / Revenue 10.03x · EV / EBITDA 27.03x
Capital structure 98% equity / 2% debt · EV / Revenue 5.68x · EV / EBITDA 26.02x
SBRA carries the larger enterprise value at $7.77B against $6.27B; POWL trades on the lower EV / Revenue multiple (5.68x vs 10.03x); POWL on the lower EV / EBITDA (26.02x vs 27.03x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SABRA HEALTH CARE REIT, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Powell Industries, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.90x
0.22x
Net debt / EBITDA
Leverage against operating earnings
8.55x
-1.39x
Cash and equivalents
Liquid reserves on the balance sheet
$71.54M
$475.53M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$2.53B
$141.75M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.